Responses to Crizotinib Can Occur in High-Level MET -Amplified Non–Small Cell Lung Cancer Independent of MET Exon 14 Alterations

Rafael Caparica, Cheng Tzu Yen, Renata A. Coudry, +4

Journal of Thoracic Oncology

High-level MetOncologyCrizotinib Can OccurMedicinePathology +10

Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial

Daniel S.W. Tan, Enriqueta Felip, Gilberto de Castro, +20

Journal of Clinical Oncology

What Is the Real Impact of Estrogen Receptor Status on the Prognosis and Treatment of HER2-Positive Early Breast Cancer?

Mariana Brandão, Rafael Caparica, Luca Malorni, +3

Clinical Cancer Research

Pulmonary Nodules in Patients With Nonpulmonary Cancer: Not Always Metastases

Rafael Caparica, Milena Perez Mak, Claudio Henrique Rocha, +6

Journal of Global Oncology

Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy

Maria Alice Franzoi, Daniel Eiger, Lieveke Ameye, +11

JNCI Journal of the National Cancer Institute

Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors

Maria Alice Franzoi, Caroline Vandeputte, Daniel Eiger, +7

Breast Cancer Research and Treatment

Tomography-based AnalysesBreast OncologyBreast Cancer PatientsMedicineBreast Cancer +6

FOLFIRI as second-line treatment of metastatic biliary tract cancer patients

Rafael Caparica, Adrien Lengelé, Winnie Bekolo, +1

Autopsy and Case Reports

Prognostic and Predictive Impact of Beta-2 Adrenergic Receptor Expression in HER2-Positive Breast Cancer

Rafael Caparica, François Richard, Mariana Brandão, +3

Clinical Breast Cancer

Tumor BiologyBreast OncologyOncologyPredictive ImpactMedicine +7

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)

Nieves Martínez Chanzá, Louisa Soukane, Philippe Barthélémy, +17

BMC Cancer

Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer

Guilherme Harada, Maria Fernanda Batistuzzo Vicentini Neffa, Renata Colombo Bonadio, +7

Jornal Brasileiro de Pneumologia